Your browser doesn't support javascript.
Serological survey for SARS-CoV-2 antibodies among tribal communities of Odisha post-second wave.
Kshatri, Jaya Singh; Bhattacharya, Debdutta; Giri, Sidhartha; Palo, Subrata Kumar; Kanungo, Srikanta; Mansingh, Asit; Parai, Debaprasad; Dany, Subha Soumya; Bisoyee, Anjan; Choudhary, Hari Ram; Sinha, Abhinav; Sahoo, Rakesh Kumar; Bhoi, Trilochan; Mohanta, Amiya Ranjan; Ota, Akhila Bihari; Mohanty, Bigyanananda; Sahoo, Uttam Kumar; Pati, Sanghamitra.
  • Kshatri JS; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Bhattacharya D; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Giri S; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Palo SK; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Kanungo S; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Mansingh A; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Parai D; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Dany SS; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Bisoyee A; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Choudhary HR; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Sinha A; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Sahoo RK; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Bhoi T; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Mohanta AR; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
  • Ota AB; Scheduled Castes and Scheduled Tribes Research and Training Institute, Bhubaneswar, Odisha, India.
  • Mohanty B; Scheduled Castes and Scheduled Tribes Research and Training Institute, Bhubaneswar, Odisha, India.
  • Sahoo UK; Scheduled Castes and Scheduled Tribes Research and Training Institute, Bhubaneswar, Odisha, India.
  • Pati S; Department of Health Research, ICMR-Regional Medical Research Centre, Ministry of Health & Family Welfare, Government of India, Bhubaneswar, Odisha, India.
Indian J Med Res ; 156(2): 284-290, 2022 08.
Article in English | MEDLINE | ID: covidwho-2110461
ABSTRACT
Background &

objectives:

Serial national level serosurveys in India have provided valuable information regarding the spread of COVID-19 pandemic in the general population, but the impact of the ongoing pandemic on the tribal population in India is not well understood. In this study, we evaluated the seroprevalence of COVID-19 antibodies in the tribal population of Odisha post-second wave (September 2021).

Methods:

A population-based, age-stratified, cross-sectional study design was adopted for the survey, carried out in seven tribal districts of Odisha from 30th August to 16th September 2021. A multistage random sampling method was used where serum samples were tested for antibodies against the SARS-CoV-2 nucleocapsid (N) protein in each district, and a weighted seroprevalence with 95 per cent confidence interval (CI) was estimated for each district.

Results:

A total of 2855 study participants were included from the seven tribal districts of Odisha in the final analysis. The overall weighted seroprevalence was 72.8 per cent (95% CI 70.1-75.3). Serological prevalence was the highest among 18-44 yr (74.4%, 95% CI 71.3-77.3) and from Sambalpur district [75.90% (66.90-83.10)]. Among participants, 41.93 per cent had received at least one dose of any COVID-19 vaccine. Kandhamal district had the highest number of fully immunized participants (24.78%), and in Sundergarh district, most of the study participants (58.1%) were unimmunized. Interpretation &

conclusions:

This study found high seroprevalence against SARS-CoV-2 in the tribal population of Odisha. The vaccination coverage is at par with the general population, and efforts to address some knowledge gaps may be needed to improve the coverage in the future.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Indian J Med Res Year: 2022 Document Type: Article Affiliation country: Ijmr.ijmr_3428_21

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Indian J Med Res Year: 2022 Document Type: Article Affiliation country: Ijmr.ijmr_3428_21